Penalized for “On-Label” Marketing? In Wake of Amarin, Pacira Files First Amendment Complaint Against FDA Read more
Purdue Pharma Settles With New York AG Over Oxycontin Promotion; Agrees To Long List of Requirements To Ensure “Responsible and Transparent Marketing” Read more
Amgen Pays $71 Million to States For Off-Label Allegations In Violation of Consumer Protection Laws Read more